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Thrombus in the left ventricle in patient after anterior wall  
myocardial infarction treated with percutaneous coronary  
intervention and dual antiplatelet therapy
Zorganizowana skrzeplina w lewej komorze powstała po zabiegu przezskórnej  
angioplastyki wieńcowej mimo stosowanej podwójnej terapii przeciwpłytkowej
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Abstract
Myocardial infarction is an acute condition which can lead to many complications in a postinfarct period (MI, myocar-
dial infarction). Left ventricular thrombus formation after successful primary percutaneous coronary intervention (PCI) 
with stenting and treating with dual antiplatelet therapy nowadays is a less common finding especially in absence of 
severe left ventricular dysfunction associated with MI. Case of 70-year-old male who was admitted to the Emergency 
Department with severe MI treating with successful primary PCI with stenting and dual antiplatelet therapy with a new 
unexpected finding of thrombus in the left ventricular apex observed in control of the echocardiography examination 
during hospitalisation despite dual antiplatelet therapy.
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Case report
A 70-year-old male was admitted to the Emergency Depart-
ment because of severe chest pain of one hour duration 
and ST-segment elevations on electrocardiogram (ECG). 
The patient had history of hypertension and chronic renal 
insufficiency. Physical examination revealed: the blood 
pressure 140/90 mm Hg, the pulse 100 beats per minu-
te, body temperature was normal, the oxygen saturation 
90% and bilateral crackles over the lung fields. Creatine 
kinase myocardial-bound (MB) fraction was elevated to 
300.30 ng/mL (reference range 0.00 to 6.73), as well as 
troponin T was 8.05 ng/mL (reference range < 0.01). In 
the laboratory examination we confirmed the symptoms 
of inflammation process: the increase value of WBC 14.8 
× 103/µL (reference range 4.0–10.0) and increased level 
of C-reactive protein (CRP) 40.42 mg/L (reference range 
0.00–5.00). A 12-lead ECG showed both sinus rhythm at 
100 beats per minute with ST-segment elevations of 2 to 
4 mm in anterior leads V1–V4 and concomitant T-wave 
inversion in leads I aVL, V5–V6.
The patient was immediately qualified to urgent coro-
narography, which revealed isolated critical stenosis 99% 
in 6th segment of left anterior descending (LAD), 90% 
stenosis in middle segment 1st marginal artery (OM1) of 
left circumflex artery (Cx) and also 80% lesion in postero-
-lateral branch of right coronary artery (RCA) (Figure 1A). 
Simultaneous percutaneous coronary intervention (PCI) of 
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LAD was performed with the implementation of everolimus 
drug-eluting stent (DES) Promus Premier 3.5 × 28 mm. 
After the procedure, the infusion of eptifibatide was con-
tinued for 12 hours. Dual antiplatelet therapy (DAPT) by 
ticagrelor (2 × 90 mg) and acetylsalicylic acid (75 mg) was 
initiated. Echo examination conducted on the next day 
revealed segmental wall motion abnormality; hypokinesis 
in the anterior and lateral wall of left ventricle (LV), with 
LV ejection fraction 51% (Figure 1E). Five days later, the 
second stage of angioplasty with implantation of everoli-
mus eluting stent Synergy 2.5 × 16 mm was performed in 
OM1 artery with optimal angiographic result. The procedu-
re was complicated with haematoma of the left forearm. 
The patient was consulted by surgeon, vascular surgeon 
and dermatologist, and according to their recommenda-
tions the accurate treatment was administrated (forearm 
elevation, gentamycin compress, low-molecular weight 
heparin [LMWH] 1 × 40 mg s.c.). During the hospitalisation, 
the evaluation of haematoma was observed from oedema, 
different stages of blisters to necrotic superficial changes. 
Because of clinically suspected pneumonia, the empirical 
antibiotic therapy by ceftriaxon and further ciprofloxacin 
was initiated. On the 13th day of hospitalisation, the control 
echo examination showed unchanged segmental wall mo-
tion abnormalities of LV (ejection fraction [EF] 48%), with 
a new unexpected finding of thrombus (size 14 × 27 mm) 
in the LV apex (Figure 1B–D). Notably, the thrombus formed 
despite dual antiplatelet therapy and LMWH treatment, 
and the infusion of unfractionated heparin (UHF) under 
control of the activated partial thromboplastin time (APTT) 
was instituted. In two subsequent echocardiograms conti-
nued two thrombi (17 × 9 mm and 25 × 24 mm) were still 
visible despite the intensification of treatment. During the 
hospitalisation, the patient’s condition deteriorated and 
the level of CRP, white blood count (WBC) and procalcito-
nin increased. Antibiotic therapy was modified according 
to sputum culture and meropenem and levofloxacin 
treatment was initiated. Due to severe pneumonia and 
hypoxemic respiratory failure the artificial ventilation was 
started, but three days later the patient died because of 
respiratory failure and cardiac arrest.
Discussion
Myocardial infarction is an acute condition, which can 
lead to many complications in a postinfarct period. LV 
Figure 1A. Coronary angiography: critical stenosis in left anterior descending (LAD) and circumflex artery (Cx); B. Triplane view with visible 
thrombus in the apex of the left ventricle (red arrow), bull’s eye-impaired contractility of the anterior and lateral wall, with global left ventri-
cular strain of –15.5; C. Apical four chamber wall — diameter of the thrombus 1.5 × 2.6 cm; D. Three-dimensional (3-D) echocardiography 
with visible thrombus; E. Bull’s eye with strain curves, impaired contractility of the anterior and lateral wall
168
Folia Cardiologica 2018, vol. 13, no. 2
www.journals.viamedica.pl/folia_cardiologica
thrombus formation prevalence was as frequent as 60% 
of patients with acute myocardial infarction (AMI) before 
thrombolytic treatment was introduced [1, 2]. Nowadays, 
the LV thrombus formation after successful primary PCI 
with stenting and treating with DAPT is a less common 
(< 10%) finding, especially in the absence of severe left 
ventricular dysfunction [3]. The risk of LV thrombus forma-
tion is highest during the first three months following AMI. 
One study showed, that about 90% of thrombi occurred two 
weeks after the index event [4]. Delewi et al. [5] indicate, 
that the most common risk factors for the development 
of LV thrombus are: large infarct sizes, severe apical asy-
nergy, LV aneurysm, anterior myocardial infarction. The 
combination of Virchow’s triad (blood stasis, endothelial 
injury and hypercoagulability) is often considered as a pre-
requisite for in vivo thrombus formation. The study on one 
hundred patients with AMI treated with PCI of the LAD and 
dual antiplatelet therapy confirmed in echocardiography 
and/or MRI among 15% of patients thrombus formation 
within the first three months after AMI [5]. The patients 
with thrombus had higher levels of serum soluble tissue 
factor (TF) and D-dimer in comparison with these without 
thrombus. On the other hand, the levels of prothrombin 
fragment 1+2 (F1+2) and endogenous thrombin poten-
tial (ETP) were significantly lower in the thrombus group 
[6]. Hypercoagulability along with large infarct size and 
probably proinflammatory activity are the main predictive 
factors in the pathogenesis of LV thrombus formation 
among patients with AMI, who are treated with DAPT. 
Anticoagulation therapy can be considered in patients 
with large anterior infarction and elevated TF and D-dimer, 
because of increased risk of LV thrombus [6].
Our patient presented several risk factors of occurring 
LV thrombus formation such as anterior location of acute 
myocardial infarction, persistent segmental wall motion 
abnormality of LV in the echocardiography (ECHO) and 
severe pneumonia. The inflammatory process in the lungs 
resulting in patient’s might stimulate the coagulation 
process, which resulted in thrombus formation despite 
the anticoagulation treatment.
In conclusion, we present a case of unexpected, 
progressive LV thrombus complicating anterior infarction 
despite early reperfusion, dual antiplatelet therapy and 
LMWH prophylaxis in a patient with borderline decreased 
ejection fraction. The key trigger of the thrombus was likely 
the severe systemic infection.
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Streszczenie
Zawał serca jest stanem ostrym, który może prowadzić do licznych powikłań we wczesnym okresie pozawałowym. 
Występowanie skrzepliny w lewej komorze u pacjentów po skutecznej pierwotnej przezskórnej angioplastyce (PCI) z im-
plantacją stentu i zastosowaniu podwójnej terapii przeciwpłytkowej (DAPT) w obecnych czasach jest mniej powszechnym 
zjawiskiem, zwłaszcza u osób bez ciężkiej pozawałowej dysfunkcji mięśnia lewej komory. Zaprezentowano przypadek 
70-letniego mężczyzny, przyjętego do kliniki z prezentacją ostrego zespołu wieńcowego leczonego skuteczną pierwotną 
PCI z implantacją stentu i zastosowaniem DAPT, u którego, mimo zastosowanej terapii, w kolejnych badaniach echokar-
diograficznych podczas hospitalizacji obserwowano skrzeplinę w koniuszku lewej komory.
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